Flexible fluorescence-cystoscopy in non-muscle-invasive bladder cancer
- Conditions
- on-muscle invasive bladder cancer
- Registration Number
- JPRN-jRCTs031230643
- Lead Sponsor
- Yoshida Soichiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
(1) Patients scheduled for TURBT for a clinical diagnosis of NMIBC
(2) Patients over 20 years old and older and under 85 years old
(3) Patients with ECOG-PS 0 or 1
(4) Patients who meet the criteria for the following clinical test reference values
-Absolute neutrophil count >= 1,500,000,000/L
-Platelet count >= 100,000,000,000/L
-Hemoglobin >= 8.5g/dL
-Blood urea nitrogen, creatinine, total bilirubin, AST and ALT <= 1.5 times ULN
(5) Patients who are willing and able to follow the study protocol, including study visits and tests.
(6) Patients who have fully understood the content of this study and have provided written consent
(1) Patients whose tumor size exceeds 2 cm
(2) Patients with a history of cardiovascular disease
(3) Patients with serious complications (uncontrolled hypertension or diabetes)
(4) Patients with interstitial pneumonia or pulmonary fibrosis
(5) Women who are or may become pregnant or breastfeeding
(6) Patients with porphyrias and current or past hypersensitivity to porphyrins
(7) Patients judged to be ineligible by the investigator for medical, psychological, or other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method